Advanced search
Publication Cover
Expert Review of Vaccines Volume 9, 2010 - Issue 4
Submit an article Journal homepage
489
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Danger signals in tumor cells: a risk factor for autoimmune disease?

Volker Schirrmacher German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. [email protected]
&
Philippe Fournier German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. [email protected]
Pages 347-350 | Published online: 09 Jan 2014

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Volker Schirrmacher, Philippe Fournier & Peter Schlag. (2014) Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function. Expert Review of Vaccines 13:1, pages 117-130.
Read now

Articles from other publishers (5)

Noorul Hamizah Mat, Siti Najmi Syuhadaa Bakar, Vikneswaran Murugaiyah, Marek C. Chawarski & Zurina Hassan. (2023) Analgesic effects of main indole alkaloid of kratom, mitragynine in acute pain animal model. Behavioural Brain Research 439, pages 114251.
Crossref
Gun-Young Jang, Ji won Lee, Young Seob Kim, Sung Eun Lee, Hee Dong Han, Kee-Jong Hong, Tae Heung Kang & Yeong-Min Park. (2020) Interactions between tumor-derived proteins and Toll-like receptors. Experimental & Molecular Medicine 52:12, pages 1926-1935.
Crossref
Hui Kian Ong, Wen Siang Tan & Kok Lian Ho. (2017) Virus like particles as a platform for cancer vaccine development. PeerJ 5, pages e4053.
Crossref
Philippe Fournier & Volker Schirrmacher. (2013) Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host. Biology 2:3, pages 936-975.
Crossref
Philippe Fournier & Volker Schirrmacher. (2010) Tumor Antigen-Dependent and Tumor Antigen-Independent Activation of Antitumor Activity in T Cells by a Bispecific Antibody-Modified Tumor Vaccine. Clinical and Developmental Immunology 2010, pages 1-12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.